CEN Biotech Statistics
Total Valuation
CEN Biotech has a market cap or net worth of 6,526.
Market Cap | 6,526 |
Enterprise Value | n/a |
Important Dates
The last earnings date was Monday, April 28, 2025.
Earnings Date | Apr 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CEN Biotech has 65.26 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 65.26M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +4.32% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.01 |
PB Ratio | -0.00 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
Current Ratio | 0.03 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -9.44 |
Interest Coverage | -3.74 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -10.10% |
Return on Invested Capital (ROIC) | -22.70% |
Return on Capital Employed (ROCE) | 68.77% |
Revenue Per Employee | 258,259 |
Profits Per Employee | -773,965 |
Employee Count | 4 |
Asset Turnover | 0.13 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.97% in the last 52 weeks. The beta is -78.92, so CEN Biotech's price volatility has been lower than the market average.
Beta (5Y) | -78.92 |
52-Week Price Change | -96.97% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 58.54 |
Average Volume (20 Days) | 271 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, CEN Biotech had revenue of 1.03 million and -3.10 million in losses. Loss per share was -0.05.
Revenue | 1.03M |
Gross Profit | 1.03M |
Operating Income | -1.32M |
Pretax Income | -3.13M |
Net Income | -3.10M |
EBITDA | -889,849 |
EBIT | -1.32M |
Loss Per Share | -0.05 |
Balance Sheet
The company has 148,151 in cash and 5.62 million in debt, giving a net cash position of -5.47 million or -0.08 per share.
Cash & Cash Equivalents | 148,151 |
Total Debt | 5.62M |
Net Cash | -5.47M |
Net Cash Per Share | -0.08 |
Equity (Book Value) | -2.11M |
Book Value Per Share | -0.03 |
Working Capital | -9.53M |
Cash Flow
In the last 12 months, operating cash flow was -590,725 and capital expenditures -4,225, giving a free cash flow of -594,950.
Operating Cash Flow | -590,725 |
Capital Expenditures | -4,225 |
Free Cash Flow | -594,950 |
FCF Per Share | -0.01 |
Margins
Gross margin is 100.00%, with operating and profit margins of -127.54% and -299.69%.
Gross Margin | 100.00% |
Operating Margin | -127.54% |
Pretax Margin | -303.21% |
Profit Margin | -299.69% |
EBITDA Margin | -86.14% |
EBIT Margin | -127.54% |
FCF Margin | n/a |
Dividends & Yields
CEN Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -48.69% |
Shareholder Yield | -48.69% |
Earnings Yield | -47,438.88% |
FCF Yield | -9,116.61% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CEN Biotech has an Altman Z-Score of -9.66. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -9.66 |
Piotroski F-Score | n/a |